Find clinical trials for Non-Small-Cell Lung Cancer in Houston, TX

Study of MGY825 single agent in adult patients with advanced non-small cell lung cancer....

This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...

with zimberelimab, and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non- ...

This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...

with separate sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) wi...

N2) NSCLC (per the 8th International Association for the Study of Lung Cancer classification). The primary objective of this study ...

is designed to degrade mutant EGFR, which is a common cause for Non-Small Cell Lung Cancer (NSCLC). This...

This is a Phase II, multi-center, open-label platform study evaluating novel combination treatment options in participants with locally advanced or m...

This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small ...

This is an open-label, multicenter, non-randomized, Phase 2 study to determine the safety, tolerability and efficacy of encorafenib given in-...